Skip to main content

Backed xStocks

Tokenised stock trackers

Tokenised Equities
#2 Overall

Ranked #2 of 8 tokenised equities in the published ranking

60 out of 100
ChainChoice ScoreThe ChainChoice Score, shown against 100: published scores run from 41 to 99.
  • High evidence confidence

Is Backed xStocks right for you?

Right for you if these matter most

  • Dividends explained7/10; the category best is 8
  • US-person answer9/10, the category best

Look elsewhere if these come first

  • Share or promise2/10 here; Securitize (tokenized SECZ) scores 10
  • Issuer named6/10 here; Securitize (tokenized SECZ) scores 9

Not yet tested for your country. Markets it lists: Europe, Asia, Latin America, Africa, Middle East & North Africa. Restricted: United States, Canada, United Kingdom, Australia, Nigeria, Philippines, Venezuela.

to test where you can use it.

The rank above is the published one, the same for every reader. Find my best tokenised equity shows where it lands for you.

What will Backed xStocks cost you?

Not priced on this basis

Your balance
$10k
How this is calculated

How safe is Backed xStocks?

  • Evidence: verified4 of 4 criteria rest on quoted, sourced receipts. Read September 2026.
  • LicenceMiCA (EU): no register record on file here.
  • On the registersMiCA: authorised, PAYWARD EUROPE SOLUTIONS LIMITED (IE, since 2025-06-25). Read 3 November 2026. Open the registerMiCA: authorised, PAYWARD GLOBAL SOLUTIONS LIMITED (IE, since 2025-06-25). Read 3 November 2026. Register
Open the evidence

Alternatives to Backed xStocks

Compare all 4
  1. 3Ondo Stocks2 points below · weaker on dividends explained (6 against 7)58 out of 100
  2. 4Securitize (tokenized SECZ)2 points below · stronger on share or promise (10 against 2)58 out of 100
  3. 5Bullish tokenized BLSH shares2 points below · stronger on share or promise (8 against 2)58 out of 100
View all 8 ranked tokenised equities

Provider at a glance

Category
Tokenised Equities
Official website
kraken.com

Independent rankingchecked How it works

Details

Scored 60 out of 100 under methodology 2026.10.18, from the evidence read in September 2026.